NCT03031730 2026-02-10Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple MyelomaNational Cancer Institute (NCI)Phase 1 Terminated35 enrolled 10 charts
NCT02547662 2023-10-30Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell LeukemiaMayo ClinicPhase 2 Completed17 enrolled 13 charts